The selling is by directors only, not C-suite executives, and the dollar amount is small relative to market cap. However, the cluster of sales at elevated prices warrants monitoring for additional insider selling or a potential catalyst announcement. The stock's strong recent performance and 95% analyst bullishness suggest the selling may be routine profit-taking rather than a negative signal.
Price Chart
Executive Summary
Two Monopar Therapeutics directors sold a total of $144K in open-market sales over a two-day window, with Kim Tsuchimoto executing six separate sales on August 26 and Raymond Anderson selling on August 25. While the dollar amount is modest relative to the $763M market cap (0.02%), the cluster of sales by multiple directors at elevated share prices near $110-$114 may signal profit-taking following the stock's significant run-up, though the small size limits bearish conviction.
Key Financial Metrics
Key Facts
- Director Kim Tsuchimoto sold 4,090 shares total on August 26 across six trades at prices from $108.83 to $113.84, totaling ~$455,567
- Director Raymond Anderson sold 3,142 shares on August 25 across three trades at $110.04-$113.05, totaling ~$351,189
- Combined open-market sales of ~$807K over the 7-day window represent ~0.11% of MNPR's $763M market cap
- No C-suite executives participated in the selling cluster
- The stock has appreciated significantly, with the $110-$114 sale prices well above recent levels
Financial Impact
Total insider sales of ~$807K over the cluster window, representing ~0.11% of market cap — below the 0.5% threshold for materiality
Risk Factors
- Insider selling could accelerate if the stock continues to rise
- No C-suite buying to offset the director selling pattern
- The stock's significant run-up increases vulnerability to profit-taking by other holders
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 1 SEC document filed with EDGAR.
| Document | Accession Number |
|---|---|
| CLUSTER Data (Synthetic) | cluster-MNPR-1787872142364 |
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Oct 5, 2026 21d ago | Insider Cluster | $79.57 | awaiting T+60 | — | $70.54 (+11.35%) |
Oct 1, 2026 25d ago | 144 | $77.97 | awaiting T+60 | — | $70.54 (−9.53%) |
Aug 28, 2026 8w ago | Insider Cluster | $111.93 | awaiting T+60 | — | $70.54 (−36.98%) |
Aug 27, 2026 8w ago | Insider Cluster | $111.89 | awaiting T+60 | — | $70.54 (−36.96%) |
Aug 25, 2026 8w ago | 144 | $113.72 | awaiting T+60 | — | $70.54 (−37.97%) |
Aug 12, 2026 10w ago | 8-K | $114.90 | awaiting T+60 | — | $70.54 (−38.61%) |
Aug 12, 2026 10w ago | Press Release | $114.90 | awaiting T+60 | — | $70.54 (−38.61%) |
Jul 22, 2026 13w ago | 8-K | $112.48 $71.80 | ▼ −36.17% | ▼ −39.43% | $70.54 (−37.29%) |
Jul 22, 2026 13w ago | Press Release | $112.48 $71.80 | ▼ −36.17% | ▼ −39.43% | $70.54 (−37.29%) |
Jun 30, 2026 16w ago | 8-K | $92.59 $89.38 | ▼ −3.47% | ▼ −7.03% | $70.54 (−23.81%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers